Switzerland
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 71.79 B
|
Dec. 31, 2023 | USD 333.72 | 0.27% |
|
Switzerland |
|
2 |
USD 51.72 B
|
Dec. 31, 2024 | USD 104.72 | -0.12% |
|
Switzerland |
|
3 |
USD 9.98 B
|
Dec. 31, 2023 | USD 46.21 | -3.47% |
|
Switzerland |
|
4 |
USD 7.24 B
|
Dec. 31, 2024 | USD 651.30 | 2.02% |
|
Switzerland |
|
5 |
USD 4.45 B
|
Dec. 31, 2023 | USD 88.99 | -0.28% |
|
Switzerland |
|
6 |
USD 2.86 B
|
Dec. 31, 2023 | USD 138.90 | -2.86% |
|
Switzerland |
|
7 |
USD 1.51 B
|
Dec. 31, 2023 | USD 1.12 K | -0.26% |
|
Switzerland |
|
8 |
USD 1.28 B
|
Dec. 31, 2023 | USD 250.45 | -3.26% |
|
Switzerland |
|
9 |
USD 1.15 B
|
Dec. 31, 2023 | USD 21.72 | -0.35% |
|
Switzerland |
|
10 |
USD 1.09 B
|
Dec. 31, 2023 | USD 15.53 | -0.65% |
|
Switzerland |
|
11 |
USD 685.70 M
|
Dec. 31, 2023 | USD 62.45 | -2.60% |
|
Switzerland |
|
12 |
USD 607.96 M
|
March 31, 2024 | USD 382.54 | -3.00% |
|
Switzerland |
|
13 |
USD 587.59 M
|
Dec. 31, 2023 | USD 1.14 K | -1.12% |
|
Switzerland |
|
14 |
USD 577.95 M
|
Dec. 31, 2023 | USD 13.36 | -0.81% |
|
Switzerland |
|
15 |
USD 563.77 M
|
Dec. 31, 2023 | USD 126.21 | -1.33% |
|
Switzerland |
|
16 |
USD 371.21 M
|
Dec. 31, 2023 | USD 41.59 | -1.07% |
|
Switzerland |
|
17 |
USD 353.61 M
|
Dec. 31, 2023 | USD 27.36 | -2.78% |
|
Switzerland |
|
18 |
USD 353.12 M
|
Dec. 31, 2023 | USD 3.57 | -5.82% |
|
Switzerland |
|
19 |
USD 288.30 M
|
Dec. 31, 2023 | USD 60.16 | -1.72% |
|
Switzerland |
|
20 |
USD 251.81 M
|
Dec. 31, 2023 | USD 74.55 | -2.22% |
|
Switzerland |
|
21 |
USD 187.23 M
|
Dec. 31, 2023 | USD 43.76 | -1.99% |
|
Switzerland |
|
22 |
USD 175.73 M
|
Dec. 31, 2023 | USD 161.30 | -1.97% |
|
Switzerland |
|
23 |
USD 122.83 M
|
Dec. 31, 2023 | USD 17.87 | -4.83% |
|
Switzerland |
|
24 |
USD 69.56 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
25 |
USD 39.87 M
|
Dec. 31, 2023 | USD 24.30 | -3.46% |
|
Switzerland |
|
26 |
USD 17.58 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
27 |
USD 8.36 M
|
Dec. 31, 2023 | USD 5.05 | -4.17% |
|
Switzerland |
|
28 |
USD 0.00
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
The Healthcare company in Switzerland with the highest Revenue is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 71.79 B.
The Healthcare company in Switzerland with the lowest Revenue is MoonLake Immunotherapeutics (NasdaqCM: MLTX) at USD 0.00.
The top 10 Healthcare companies in Switzerland by Revenue are Roche Holding AG, Novartis AG, Sandoz Group AG, Lonza Group AG, Galenica AG, Straumann Holding AG, Siegfried Holding AG, Tecan Group AG, DocMorris AG and Aevis Victoria SA.
The bottom 10 Healthcare companies in Switzerland by Revenue are MoonLake Immunotherapeutics, Molecular Partners AG, AC Immune SA, Kuros Biosciences AG, ADC Therapeutics SA, Santhera Pharmaceuticals Holding AG, IVF Hartmann Holding AG, Basilea Pharmaceutica AG, Medartis Holding AG and COLTENE Holding AG.